Lysine HCl manufacturers keep pushing prices higher with some success, and some Q4 buying is seen, though many buyers are waiting until after summer. Threonine has quieted with first price declines in fresh offers, while vitamin prices show little reaction to a European vitamin producer's restructuring news.
Firm lysine offers support feed amino acid costs, while softening threonine and quiet vitamins point to mixed pressure on premix formulation costs.
Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.